Cargando…

Randomized placebo‐controlled trial of losartan for pediatric NAFLD

BACKGROUND AND AIMS: To date, no pharmacotherapy exists for pediatric NAFLD. Losartan, an angiotensin II receptor blocker, has been proposed as a treatment due to its antifibrotic effects. APPROACH AND RESULTS: The Nonalcoholic Steatohepatitis Clinical Research Network conducted a multicenter, doubl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vos, Miriam B., Van Natta, Mark L., Blondet, Niviann M., Dasarathy, Srinivasan, Fishbein, Mark, Hertel, Paula, Jain, Ajay K., Karpen, Saul J., Lavine, Joel E., Mohammad, Saeed, Miriel, Laura A., Molleston, Jean P., Mouzaki, Marialena, Sanyal, Arun, Sharkey, Emily P., Schwimmer, Jeffrey B., Tonascia, James, Wilson, Laura A., Xanthakos, Stavra A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288975/ https://www.ncbi.nlm.nih.gov/pubmed/35133671 http://dx.doi.org/10.1002/hep.32403

Ejemplares similares

Longitudinal Assessment of High Blood Pressure in Children with Nonalcoholic Fatty Liver Disease
por: Schwimmer, Jeffrey B., et al.
Publicado: (2014)

Evolving Role for Pharmacotherapy in NAFLD/NASH
por: Attia, Suzanna L., et al.
Publicado: (2020)

FRI591 Association Of TSH Levels And NAFLD Severity In Children And Adolescents
por: Untalan, Matthew, et al.
Publicado: (2023)

More Frequent Clinic Visits Are Associated with Improved Outcomes for Children with NAFLD
por: Lam, Carol, et al.
Publicado: (2016)

Clinical Model for NASH and Advanced Fibrosis in Adult Patients With Diabetes and NAFLD: Guidelines for Referral in NAFLD
por: Bazick, Jessica, et al.
Publicado: (2015)

Validation of the accuracy of the FAST(™) score for detecting patients with at-risk nonalcoholic steatohepatitis (NASH) in a North American cohort and comparison to other non-invasive algorithms
por: Woreta, Tinsay A., et al.
Publicado: (2022)

Hepatic Nuclear Receptor Expression Associates with Features of Histology in Pediatric Nonalcoholic Fatty Liver Disease
por: Elbel, Erin E., et al.
Publicado: (2018)

Health-Related Social Needs Facing Youth With Nonalcoholic Fatty Liver Disease
por: Orkin, Sarah, et al.
Publicado: (2021)

Effects of losartan in patients with NAFLD: A meta-analysis of randomized controlled trial
por: Meng, Chang, et al.
Publicado: (2023)

Portal Bypass Complicated by Hepatopulmonary Syndrome
por: Monroe, Eric J., et al.
Publicado: (2021)

Non-alcoholic steatohepatitis: the therapeutic challenge of a global epidemic
por: Mouzaki, Marialena, et al.
Publicado: (2012)

Insights into the evolving role of the gut microbiome in nonalcoholic fatty liver disease: rationale and prospects for therapeutic intervention
por: Mouzaki, Marialena, et al.
Publicado: (2019)

Effect of liquid and solid test meals on symptoms and gastric myoelectrical activity in patients with gastroparesis and functional dyspepsia
por: Koch, Kenneth L., et al.
Publicado: (2022)

Losartan Prevents Hepatic Steatosis and Macrophage Polarization by Inhibiting HIF-1α in a Murine Model of NAFLD
por: Wang, Cheng-Hui, et al.
Publicado: (2021)

Adherence to vitamin supplementation following adolescent bariatric surgery
por: Modi, Avani C., et al.
Publicado: (2013)

Alanine Aminotransferase as a Monitoring Biomarker in Children with Nonalcoholic Fatty Liver Disease: A Secondary Analysis Using TONIC Trial Data
por: Arsik, Idil, et al.
Publicado: (2018)

A randomized, controlled, crossover pilot study of losartan for pediatric nonalcoholic fatty liver disease
por: Vos, Miriam B., et al.
Publicado: (2018)

Association of Histologic Disease Activity With Progression of Nonalcoholic Fatty Liver Disease
por: Kleiner, David E., et al.
Publicado: (2019)

Losartan-induced Pancreatitis
por: Anwar, Shamsuddin M, et al.
Publicado: (2019)

A Rare Case of Losartan-Induced Visceral Angioedema
por: Rosas, Steven, et al.
Publicado: (2023)

Bariatric Surgery Meaningfully and Durably Improves Long-term Outcomes in Adolescents with Severe Obesity
por: Inge, Thomas H., et al.
Publicado: (2017)

Comparison of the GPVI inhibitors losartan and honokiol
por: Onselaer, Marie-Blanche, et al.
Publicado: (2019)

Is the combination of enalapril and losartan irrational?
por: Parmar, D.M., et al.
Publicado: (2008)

The nonalcoholic steatohepatitis extended hepatocyte ballooning score: histologic classification and clinical significance
por: Gill, Ryan M., et al.
Publicado: (2023)

Anti-Epileptogenesis: Some Roads Lead to Losartan
por: Sarkis, Rani A.
Publicado: (2023)

Prevalence of at-risk NASH and its association with metabolic syndrome in US adults with NAFLD, 2017–2018
por: Payne, Julia Y., et al.
Publicado: (2023)

Study protocol: a prospective controlled clinical trial to assess surgical or medical treatment for paediatric type 2 diabetes (ST(2)OMP)
por: Shah, Amy S, et al.
Publicado: (2021)

IR microspectroscopic investigation of the interaction of some losartan salts with human stratum corneum protein and its effect on losartan transdermal permeation
por: Mansour, Randa S. H., et al.
Publicado: (2023)

Pilot Testing of a Patient Decision Aid for Adolescents with Severe Obesity in US Pediatric Weight Management Programs within the COMPASS Network
por: Moore, Jaime, et al.
Publicado: (2019)

Comparison of Pharmacokinetics of a Fixed-Dose Combination of Amlodipine/Losartan/Rosuvastatin with Concomitant Administration of Amlodipine/Losartan and Rosuvastatin in Healthy Volunteers
por: Yoon, Deok Yong, et al.
Publicado: (2020)

Weight increase in people with cystic fibrosis on CFTR modulator therapy is mainly due to increase in fat mass
por: Mouzaki, Marialena, et al.
Publicado: (2023)

Losartan Interactions with 2-Hydroxypropyl-β-CD
por: Palli, Vasiliki, et al.
Publicado: (2022)

LPCN 1144 Resolves NAFLD in Hypogonadal Males
por: Albhaisi, Somaya, et al.
Publicado: (2020)

The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan
por: García Trejo, Ehécatl Miguel Ángel, et al.
Publicado: (2017)

Editorial: The heart of NAFLD
por: Chew, Nicholas W. S., et al.
Publicado: (2023)

Fixed combination of losartan and hydrochlorothiazide and reduction of risk of stroke
por: Kjeldsen, Sverre E, et al.
Publicado: (2007)

Efficacy and safety of single-pill amlodipine/losartan versus losartan in patients with inadequately controlled hypertension after losartan treatment: a multicenter, double-blind, randomized phase III clinical trial
por: Zhang, Shuyang, et al.
Publicado: (2023)

Fifteen years of losartan: what have we learned about losartan that can benefit chronic kidney disease patients?
por: Ripley, Elizabeth, et al.
Publicado: (2010)

The therapeutic potential of losartan in lung metastasis of colorectal cancer
por: Hashemzehi, Milad, et al.
Publicado: (2020)

Parental Perceptions of Quality of Life in Children on Long-Term Ventilation at Home as Compared to Enterostomy Tubes
por: Redouane, Brahim, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_61iejfbgrk4ice777pv1ni8rb7